Use your antibodies-online credentials, if available.
Il n’y a pas de produits dans votre liste de comparaison.
Votre panier est vide.
Afficher toutes les espèces
Afficher tous les synonymes
Select your species
A yopH mutant survived better in the absence of neutrophils, indicating that neutrophil inactivation by YopH by targeting PRAM-1/SKAP-HOM (Montrer SKAP2 Kits ELISA) and SLP-76 (Montrer LCP2 Kits ELISA)/Vav (Montrer VAV1 Kits ELISA)/PLCgamma2 (Montrer PLCG2 Kits ELISA) signaling hubs may be critical for Yersinia survival.
autophagy contributes to the anti-apoptotic function of the PML (Montrer PML Kits ELISA)-RARalpha (Montrer RARA Kits ELISA) protein through inhibiting the Akt (Montrer AKT1 Kits ELISA)/mTOR (Montrer FRAP1 Kits ELISA) pathway
Transgenic mice expressing PML-RAR alpha (Montrer RARA Kits ELISA) develop acute promyelocytic leukemia (Montrer PML Kits ELISA) with long latency, low penetrance, and acquired cytogenetic abnormalities.
Our results show that the pretreatment PML (Montrer PML Kits ELISA)-RARA (Montrer RARA Kits ELISA) molecular burden could therefore be used to improve risk stratification in order to develop more individualized treatment regimens for high-risk APL (Montrer FASL Kits ELISA) cases.
The 3-plex RT-qPCR assay is a specific, sensitive, stable, and cost-effective method that can be used for the rapid diagnosis and treatment monitoring of acute promyelocytic leukemia (Montrer PML Kits ELISA) with PML (Montrer PML Kits ELISA)-RARa (Montrer RARA Kits ELISA)
The MIR125B1-mediated blockade of PML (Montrer PML Kits ELISA)-RARA (Montrer RARA Kits ELISA) proteolysis was regulated via an autophagy-lysosomal pathway, contributing to the inhibition of acute promyelocytic leukemia (Montrer PML Kits ELISA) differentiation.
PRAM-1 is required for optimal integrin-dependent neutrophil function.
Caspase 3 (Montrer CASP3 Kits ELISA)-cleaved SH3 domain (Montrer ITSN1 Kits ELISA) of HIP-55 (Montrer DBNL Kits ELISA) is likely involved in PRAM-1-mediated JNK (Montrer MAPK8 Kits ELISA) activation upon arsenic trioxide-induced differentiation of NB4 cells.
The use of reverse-transcription polymerase chain reaction for the detection of the PML (Montrer PML Kits ELISA)-RARA (Montrer RARA Kits ELISA) and RARA (Montrer RARA Kits ELISA)-PML (Montrer PML Kits ELISA) fusion genes that allow for monitoring of acute myelocytic leukemia.
PML (Montrer PML Kits ELISA)-RARalpha (Montrer RARA Kits ELISA) fusion transcripts have been shown to be useful markers for establishing the diagnosis and for monitoring the response to treatment of acute promyelocytic leukemia (Montrer PML Kits ELISA).
Interaction of PRAM-1 and hSH3 domains of adhesion and degranulation promoting adapter protein (Montrer TOLLIP Kits ELISA) (ADAP (Montrer FYB Kits ELISA)) with phosphatidylcholine (Montrer SGMS2 Kits ELISA)-containing liposomes is observed upon incorporation of phosphatidylserine or phosphoinositides into the membrane bilayer.
hidden abnormalities and novel disease-related genomic changes occur in t(15;17)translocation in acute promyelocytic leukemia (Montrer PML Kits ELISA) formation of PML (Montrer PML Kits ELISA)-RARA (Montrer RARA Kits ELISA) gene
The protein encoded by this gene is similar to FYN binding protein (FYB/SLAP-130), an adaptor protein involved in T cell receptor mediated signaling. This gene is expressed and regulated during normal myelopoiesis. The expression of this gene is induced by retinoic acid and is inhibited by the expression of PML-RARalpha, a fusion protein of promyelocytic leukemia (PML) and the retinoic acid receptor-alpha (RARalpha).
PML-RARA regulated adaptor molecule 1
, PML-RARA-regulated adapter molecule 1-like
, PML-RARA-regulated adapter molecule 1
, PML-RARA target gene encoding an Adaptor Molecule-1
, PML-RAR alpha-regulated adaptor molecule 1